clopidogrel and Carcinogenesis

clopidogrel has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, C; Guo, H; Li, B; Liu, Y; Liu, YJ; Xu, J; Zhang, R; Zhao, Y; Zhou, C	1

Other Studies

1 other study(ies) available for clopidogrel and Carcinogenesis

Article	Year
Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding. Oncotarget, 2016, Sep-13, Volume: 7, Issue:37 Topics: Adenosine Diphosphate; Aged; Animals; Blood Platelets; Carcinogenesis; Carcinoma, Hepatocellular; Cell Differentiation; Clopidogrel; Female; Hep G2 Cells; Humans; Intercellular Junctions; Liver Neoplasms; Male; Mice; Mice, SCID; Middle Aged; P-Selectin; Platelet Activation; Protein Binding; RNA, Small Interfering; Ticlopidine; Transcription Factor 4; Tumor Microenvironment; Xenograft Model Antitumor Assays	2016

Article

Year

Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding.

Oncotarget, 2016, Sep-13, Volume: 7, Issue:37

Topics: Adenosine Diphosphate; Aged; Animals; Blood Platelets; Carcinogenesis; Carcinoma, Hepatocellular; Cell Differentiation; Clopidogrel; Female; Hep G2 Cells; Humans; Intercellular Junctions; Liver Neoplasms; Male; Mice; Mice, SCID; Middle Aged; P-Selectin; Platelet Activation; Protein Binding; RNA, Small Interfering; Ticlopidine; Transcription Factor 4; Tumor Microenvironment; Xenograft Model Antitumor Assays

2016